From public campaigns featuring Cyndi Lauper to ads with dinosaurs, MM+M compiles the best public marketing campaigns from ...

Navigating the large universe of small-cap stocks can be a daunting task, which is why most investors leave the stock picking ...

Patients would pay no more than $25 for certain name-brand medications to treat chronic illnesses, and face no costs for ...

The bill would add scrutiny to pharmacy benefit managers and eliminate or cap out-of-pocket costs for drugs that treat ...

Asthma inhalers are hand-held devices that allow ... Within each class of inhaled asthma medication are different drugs with ...

Aptar, Clearway Energy, and Darling are among sustainable holdings. Finding the small-cap stocks that are uniquely owned by ...

A new year, new breakthroughs! Join us for our annual tradition of compiling and revealing the most interesting things ...

The selected name brand drug won’t be subject to any deductible ... mechanisms” to manage chronic illnesses, like needles, inhalers and monitors, was not included in the final compromise ...